Pasithea Therapeutics Corp.
KTTANasdaqCIK 1841330HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | 1.6Research and development, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001213900-24-097496.Report this figure | 3.4Research and development, Q4 FY2023, three months to 2023-12-31$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-24, accession 0001013762-25-001646. Derived: 12-month figure less the 9-month figure.Report this figure | 1.7Research and development, Q1 FY2024, three months to 2024-03-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001213900-25-044281.Report this figure | 2.4Research and development, Q2 FY2024, three months to 2024-06-30$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001213900-25-076557.Report this figure | 1.6Research and development, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 1.5Research and development, Q4 FY2024, three months to 2024-12-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001213900-26-036434. Derived: 12-month figure less the 9-month figure.Report this figure | 1.7Research and development, Q1 FY2025, three months to 2025-03-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | 2.1Research and development, Q2 FY2025, three months to 2025-06-30$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 1.4Research and development, Q3 FY2025, three months to 2025-09-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 2.7Research and development, Q4 FY2025, three months to 2025-12-31$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001213900-26-036434. Derived: 12-month figure less the 9-month figure.Report this figure | 2.9Research and development, Q1 FY2026, three months to 2026-03-31$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | 3.7Research and development, Q2 FY2026, three months to 2026-06-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
| Selling, general and administrative | $m | 2.2Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2023-11-13, accession 0001213900-23-086198.Report this figure | 1.8Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$1.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-24, accession 0001013762-25-001646. Derived: 12-month figure less the 9-month figure.Report this figure | 2.3Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-05-14, accession 0001213900-24-042981.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | (3.8)Operating income, Q3 FY2023, three months to 2023-09-30−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001213900-24-097496.Report this figure | (5.1)Operating income, Q4 FY2023, three months to 2023-12-31−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0001013762-25-001646. Derived: 12-month figure less the 9-month figure.Report this figure | (4.0)Operating income, Q1 FY2024, three months to 2024-03-31−$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001213900-25-044281.Report this figure | (3.9)Operating income, Q2 FY2024, three months to 2024-06-30−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001213900-25-076557.Report this figure | (3.0)Operating income, Q3 FY2024, three months to 2024-09-30−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | (3.3)Operating income, Q4 FY2024, three months to 2024-12-31−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-036434. Derived: 12-month figure less the 9-month figure.Report this figure | (3.7)Operating income, Q1 FY2025, three months to 2025-03-31−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | (3.8)Operating income, Q2 FY2025, three months to 2025-06-30−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | (3.1)Operating income, Q3 FY2025, three months to 2025-09-30−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | (10.3)Operating income, Q4 FY2025, three months to 2025-12-31−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-036434. Derived: 12-month figure less the 9-month figure.Report this figure | (4.9)Operating income, Q1 FY2026, three months to 2026-03-31−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | (5.7)Operating income, Q2 FY2026, three months to 2026-06-30−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | (3.6)Net income, Q3 FY2023, three months to 2023-09-30−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001213900-24-097496.Report this figure | (5.0)Net income, Q4 FY2023, three months to 2023-12-31−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0001013762-25-001646. Derived: 12-month figure less the 9-month figure.Report this figure | (3.9)Net income, Q1 FY2024, three months to 2024-03-31−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | (3.9)Net income, Q2 FY2024, three months to 2024-06-30−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | (3.0)Net income, Q3 FY2024, three months to 2024-09-30−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | (3.2)Net income, Q4 FY2024, three months to 2024-12-31−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-036434. Derived: 12-month figure less the 9-month figure.Report this figure | (3.6)Net income, Q1 FY2025, three months to 2025-03-31−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | (3.7)Net income, Q2 FY2025, three months to 2025-06-30−$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | (3.0)Net income, Q3 FY2025, three months to 2025-09-30−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | (10.1)Net income, Q4 FY2025, three months to 2025-12-31−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001213900-26-036434. Derived: 12-month figure less the 9-month figure.Report this figure | (2.9)Net income, Q1 FY2026, three months to 2026-03-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | (5.3)Net income, Q2 FY2026, three months to 2026-06-30−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
| Diluted EPS | $ per share | 0.00Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-11-13, accession 0001213900-23-086198.Report this figure | not reported | (3.70)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$3.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001213900-25-044281.Report this figure | (3.71)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$3.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001213900-25-076557.Report this figure | (2.87)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$2.87 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | not reported | (1.61)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | (0.66)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | (0.41)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | not reported | (0.12)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | (0.16)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
| Basic EPS | $ per share | 0.00Basic EPS, Q3 FY2023, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2023-11-13, accession 0001213900-23-086198.Report this figure | not reported | (3.70)Basic EPS, Q1 FY2024, three months to 2024-03-31−$3.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001213900-25-044281.Report this figure | (3.71)Basic EPS, Q2 FY2024, three months to 2024-06-30−$3.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001213900-25-076557.Report this figure | (2.87)Basic EPS, Q3 FY2024, three months to 2024-09-30−$2.87 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | not reported | (1.61)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | (0.66)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | (0.41)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | not reported | (0.12)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | (0.16)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 19.6Cash and equivalents, Q3 FY2023, at 2023-09-30$19.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001213900-23-086198.Report this figure | 16.3Cash and equivalents, FY2023, at 2023-12-31$16.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-24, accession 0001013762-25-001646.Report this figure | 12.0Cash and equivalents, Q1 FY2024, at 2024-03-31$12.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001213900-24-042981.Report this figure | 8.0Cash and equivalents, Q2 FY2024, at 2024-06-30$8.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001213900-24-068297.Report this figure | 9.4Cash and equivalents, Q3 FY2024, at 2024-09-30$9.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 6.9Cash and equivalents, FY2024, at 2024-12-31$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001213900-26-036434.Report this figure | 5.3Cash and equivalents, Q1 FY2025, at 2025-03-31$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | 7.2Cash and equivalents, Q2 FY2025, at 2025-06-30$7.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 4.1Cash and equivalents, Q3 FY2025, at 2025-09-30$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 55.2Cash and equivalents, FY2025, at 2025-12-31$55.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 50.4Cash and equivalents, Q1 FY2026, at 2026-03-31$50.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | 45.7Cash and equivalents, Q2 FY2026, at 2026-06-30$45.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
| Current assets | $m | 20.8Current assets, Q3 FY2023, at 2023-09-30$20.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001213900-23-086198.Report this figure | 16.7Current assets, FY2023, at 2023-12-31$16.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-24, accession 0001013762-25-001646.Report this figure | 13.2Current assets, Q1 FY2024, at 2024-03-31$13.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001213900-24-042981.Report this figure | 8.6Current assets, Q2 FY2024, at 2024-06-30$8.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-068297.Report this figure | 9.8Current assets, Q3 FY2024, at 2024-09-30$9.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001213900-24-097496.Report this figure | 7.4Current assets, FY2024, at 2024-12-31$7.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001213900-26-036434.Report this figure | 6.1Current assets, Q1 FY2025, at 2025-03-31$6.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001213900-25-044281.Report this figure | 8.6Current assets, Q2 FY2025, at 2025-06-30$8.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076557.Report this figure | 5.5Current assets, Q3 FY2025, at 2025-09-30$5.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 56.5Current assets, FY2025, at 2025-12-31$56.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 52.7Current assets, Q1 FY2026, at 2026-03-31$52.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | 48.2Current assets, Q2 FY2026, at 2026-06-30$48.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
| Total assets | $m | 30.7Total assets, Q3 FY2023, at 2023-09-30$30.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001213900-23-086198.Report this figure | 26.1Total assets, FY2023, at 2023-12-31$26.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-24, accession 0001013762-25-001646.Report this figure | 22.4Total assets, Q1 FY2024, at 2024-03-31$22.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001213900-24-042981.Report this figure | 17.7Total assets, Q2 FY2024, at 2024-06-30$17.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001213900-24-068297.Report this figure | 18.6Total assets, Q3 FY2024, at 2024-09-30$18.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001213900-24-097496.Report this figure | 16.1Total assets, FY2024, at 2024-12-31$16.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001213900-26-036434.Report this figure | 14.7Total assets, Q1 FY2025, at 2025-03-31$14.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001213900-25-044281.Report this figure | 17.0Total assets, Q2 FY2025, at 2025-06-30$17.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001213900-25-076557.Report this figure | 13.6Total assets, Q3 FY2025, at 2025-09-30$13.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 60.2Total assets, FY2025, at 2025-12-31$60.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 56.4Total assets, Q1 FY2026, at 2026-03-31$56.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | 51.7Total assets, Q2 FY2026, at 2026-06-30$51.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
| Current liabilities | $m | 2.0Current liabilities, Q3 FY2023, at 2023-09-30$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001213900-23-086198.Report this figure | 2.6Current liabilities, FY2023, at 2023-12-31$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-24, accession 0001013762-25-001646.Report this figure | 2.5Current liabilities, Q1 FY2024, at 2024-03-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001213900-24-042981.Report this figure | 1.4Current liabilities, Q2 FY2024, at 2024-06-30$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-068297.Report this figure | 0.7Current liabilities, Q3 FY2024, at 2024-09-30$660.4k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001213900-24-097496.Report this figure | 1.1Current liabilities, FY2024, at 2024-12-31$1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001213900-26-036434.Report this figure | 1.6Current liabilities, Q1 FY2025, at 2025-03-31$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001213900-25-044281.Report this figure | 1.7Current liabilities, Q2 FY2025, at 2025-06-30$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076557.Report this figure | 1.4Current liabilities, Q3 FY2025, at 2025-09-30$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 5.0Current liabilities, FY2025, at 2025-12-31$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 1.5Current liabilities, Q1 FY2026, at 2026-03-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | 1.8Current liabilities, Q2 FY2026, at 2026-06-30$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
| Total liabilities | $m | 2.3Total liabilities, Q3 FY2023, at 2023-09-30$2.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001213900-23-086198.Report this figure | 2.7Total liabilities, FY2023, at 2023-12-31$2.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-24, accession 0001013762-25-001646.Report this figure | 2.5Total liabilities, Q1 FY2024, at 2024-03-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001213900-24-042981.Report this figure | 1.5Total liabilities, Q2 FY2024, at 2024-06-30$1.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001213900-24-068297.Report this figure | 0.8Total liabilities, Q3 FY2024, at 2024-09-30$824.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001213900-24-097496.Report this figure | 1.3Total liabilities, FY2024, at 2024-12-31$1.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001213900-26-036434.Report this figure | 1.7Total liabilities, Q1 FY2025, at 2025-03-31$1.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001213900-25-044281.Report this figure | 1.8Total liabilities, Q2 FY2025, at 2025-06-30$1.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001213900-25-076557.Report this figure | 1.4Total liabilities, Q3 FY2025, at 2025-09-30$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 5.0Total liabilities, FY2025, at 2025-12-31$5.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 1.5Total liabilities, Q1 FY2026, at 2026-03-31$1.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | 1.9Total liabilities, Q2 FY2026, at 2026-06-30$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
| Shareholders' equity | $m | 28.4Shareholders' equity, Q3 FY2023, at 2023-09-30$28.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001213900-24-097496.Report this figure | 23.4Shareholders' equity, FY2023, at 2023-12-31$23.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001213900-26-036434.Report this figure | 19.9Shareholders' equity, Q1 FY2024, at 2024-03-31$19.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 16.2Shareholders' equity, Q2 FY2024, at 2024-06-30$16.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 17.8Shareholders' equity, Q3 FY2024, at 2024-09-30$17.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 14.8Shareholders' equity, FY2024, at 2024-12-31$14.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 13.0Shareholders' equity, Q1 FY2025, at 2025-03-31$13.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 15.2Shareholders' equity, Q2 FY2025, at 2025-06-30$15.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 12.2Shareholders' equity, Q3 FY2025, at 2025-09-30$12.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001213900-25-110093.Report this figure | 55.2Shareholders' equity, FY2025, at 2025-12-31$55.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 54.8Shareholders' equity, Q1 FY2026, at 2026-03-31$54.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure | 49.8Shareholders' equity, Q2 FY2026, at 2026-06-30$49.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-090146.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $k | (3,238)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. 10-Q filed 2024-11-13, accession 0001213900-24-097496. Derived: 9-month figure less the 6-month figure.Report this figure | (3,294)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. 10-K filed 2025-03-24, accession 0001013762-25-001646. Derived: 12-month figure less the 9-month figure.Report this figure | (4,321)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001213900-25-044281.Report this figure | (4,039)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001213900-25-076557. Derived: 6-month figure less the 3-month figure.Report this figure | (3,120)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001213900-25-110093. Derived: 9-month figure less the 6-month figure.Report this figure | (2,443)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001213900-26-036434. Derived: 12-month figure less the 9-month figure.Report this figure | (3,056)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | (3,869)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-090146. Derived: 6-month figure less the 3-month figure.Report this figure | (2,890)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001213900-25-110093. Derived: 9-month figure less the 6-month figure.Report this figure | (5,397)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001213900-26-036434. Derived: 12-month figure less the 9-month figure.Report this figure | (4,787)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001213900-26-057837.Report this figure | (4,708)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-090146. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $k | (22.7)Capital expenditure, Q3 FY2023, three months to 2023-09-30−$22.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001213900-24-097496. Derived: 9-month figure less the 6-month figure.Report this figure | (0.0)Capital expenditure, Q4 FY2023, three months to 2023-12-31−$36. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-24, accession 0001013762-25-001646. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | 0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-24, accession 0001013762-25-001646. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
Shares
| Line item | Unit | Q3 FY20222022-09-30 | Q1 FY20232023-03-31 | Q2 FY20232023-06-30 | Q3 FY20232023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 26.5 | 1.3 | 1.3 | 1.3 | 1.0 | 1.0 | 1.0 | 2.2 | 5.6 | 7.4 | 24.3 | 32.1 |
Shares outstanding: 33.41m at Aug 12, 2026, from the cover of the 10-Q filed Aug 14, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.